A novel three-pronged approach to kill cancer cells selectively: Concomitant viral, double suicide gene, and radiotherapy

Human Gene Therapy

Volumn 9, Issue 9, 1998, Pages 1323-1333

  Freytag, Svend O ^a   Rogulski, Kenneth R ^a   Paielli, Dell L ^a   Gilbert, Jeff D ^a   Kim, Jae H O ^a  

^a HENRY FORD HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYTOSINE DEAMINASE; PROTEIN P53; THYMIDINE KINASE;

ANTINEOPLASTIC ACTIVITY; ARTICLE; CANCER CELL DESTRUCTION; CANCER RADIOTHERAPY; CONTROLLED STUDY; GENE FUSION; GENE THERAPY; GENETIC TRANSDUCTION; HERPES SIMPLEX VIRUS; HUMAN; HUMAN CELL; SUICIDE GENE; VIRUS REPLICATION;

ADENOVIRIDAE; HERPES; HUMAN HERPESVIRUS 1; ONYX;

EID: 0032503659     PISSN: 10430342     EISSN: None     Source Type: Journal    
DOI: 10.1089/hum.1998.9.9-1323     Document Type: Article

References (16)

1. ALBRIGHT, N. (1987). Computer programs for the analysis of cellular survival data. Radiat. Res. 112, 331-340.
2. BISCHOFF. J.R., KIRN, D.H., WILLIAMS, A., HEISE, C., HORN, S., MUNA, M., NG, L., NYE, J., SAMPSON-JOHANNES, A. FATTAEY, A., and McCORMICK, F. (1996). An adenovirus mutant that replicates selectively in p53-deficient human tumor cells. Science 274, 373-376.
3. CALABRESI, P., CHABNER, B.A. (1990). Antineoplastic agents. In A.G. Oilman, T. Rall, A.S. Nies, and P. Taylor, eds. Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed. (Pergamon Press, New York) pp. 1209-1263.
4. CHEN, S.H., SHINE, H.D., GOODMAN, J.C., GROSSMAN, R.G., and WOO, S.L.C. (1994). Gene therapy for brain tumors: Regression of experimental gliomas by adenovirus-mediated gene transfer in vivo. Proc. Natl. Acad. Sci. USA 91, 3054-3057.
5. COOL, V., PIROTTE, B., GERARD, C., DARGENT, J.-L., BAUDSON, N., LEVIVIER, M., GOLDMAN, S., HILDEBRAND, J., BROTCHI, J., and VELU, T. (1996). Curative potential of herpes simplex virus thymidine kinase gene transfer in rats with 9L gliosarcoma. Hum. Gene Ther. 7, 627-635.
6. CULVER, K.W., RAM, Z., WALLBRIDGE, S., ISHII, H., OLDFIELD, E.H., and BLAESE, R.M. (1992). In vivo gene transfer with retroviral vector-producer cells for treatment of experimental brain tumors. Science 256, 1550-1552.
7. DECLERCQ, E. (1984). Biochemical aspects of the selective antiherpes activity of nucleoside analogues. Biochem. Pharmacol. 33, 2159-2169.
8. DONG, Y., WEN, P., MANOME, Y., PARR, M., HIRSHOWTTZ, A., CHEN, L., HIRSCHOWITZ, E.A., CRYSTAL, R., WEICHSELBAUM, R., KUFE, D.W., and FINE, H.A. (1996). In vivo replication-deficient adenovirus vector-mediated transduction of the cytosine deaminase gene sensitizes glioma cells to 5-fluorocytosine. Hum. Gene Ther. 7, 713-720.
9. EZZEDDINE, Z.D., MARTUZA, R.L., PLATIKA, D., SHORT, M.P., MALICK, A., CHOI, B., and BREAKEFIELD, X.O. (1991). Selective killing of glioma cells in culture and in vivo by retrovirus transfer of the herpes simplex virus thymidine kinase gene. The New Biol. 3, 608-614.
10. GINGERAS, T.R., SCIAKY, D., GELINAS, R.E., BING-DONG, J., YEN, C.E., KELLY, M., et al. (1982). Nucleotide sequence from the adenovirus-2 genome. J. Biol. Chem. 257, 13475-13491.
11. HEISE, C., SAMPSON-JOHANNES, A., WILLIAMS, A., McCORMICK, F., VON HOFF, D.D., and KIRN, D.H. (1997). ONYX015, an E1B gene-attenuated adenovirus, causes tumor-specific cytolysis and antitumoral efficacy that can be augmented by standard chemotherapeutic agents. Nature Med. 3, 639-645.
12. HIRSCHOWITZ, E.A., OHWADA, A., PASCAL, W.R., RUSSI, T.J., and CRYSTAL, R.G. (1995). In vivo adenovirus-mediated gene transfer of the Escherichia coli cytosirte deaminase gene to human colon carcinoma-derived tumors induces chemosensitivity to 5-fluorocytosine. Hum. Gene Ther. 6, 1055-1063.
13. HUBER, B.E., AUSTIN, E.A., GOOD, S.S., KNICK, V.C., TIBBELS, S., and RICHARDS, C.A. (1993). In vivo antitumor activity of 5-fluorocytosine on human colorectal carcinoma cells genetically modified to express cytosine deaminase. Cancer Res. 53, 4619-41626.
14. TAKAMIYA, Y., SHORT, M.P., MOOLTEN, F.I., FLEET, C., Mineta, T., BREAKEFIELD, X.O., and MARTUZZA, R.L. (1993). An experimental model of retrovirus gene therapy for malignant brain tumors. J. Neurosurg. 79, 104-110.
15. YANG, G., STAPLETON, A., WHEELER T., TRUONG, L., TIMME, T., SCARDINO, P., and THOMPSON, T. (1996). Clustered p53 immunostaining: a novel pattern associated with prostate cancer progression. Clin. Cancer Res. 2, 399-401.
16. YEW, P.R., and BURKE, A.J. (1992). Inhibition of p53 transactivation required for transformation by adenovirus early 1B protein. Nature 357, 82-85.